NCT07206199 Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial
| NCT ID | NCT07206199 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Mental Health, Czech Republic |
| Condition | Obsessive-compulsive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-03-20 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-03-20 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-subject design for comparison. Patients first complete informed consent and baseline questionnaires and are placed on a waiting list for five weeks. After this period, they are reassigned to the active (experimental) group, which will receive five sessions of exposure therapy in virtual reality over a subsequent five-week period. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11 * Fluent in Czech Exclusion Criteria: * Any other psychiatric, neurological and serious somatic illness * Substance abuse * Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics. * Contradictions to using a virtual reality (e.g., epilepsy, balance problems) * Pregnancy * Cardiostimulator and mental implants
Contact & Investigator
Iveta Hocko Fajnerová, Ph.D.
STUDY DIRECTOR
National Institute of Mental Health (NIMH)
Frequently Asked Questions
Who can join the NCT07206199 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Obsessive-compulsive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07206199 currently recruiting?
Yes, NCT07206199 is actively recruiting participants. Contact the research team at iveta.fajnerova@nudz.cz for enrollment information.
Where is the NCT07206199 trial being conducted?
This trial is being conducted at Klecany, Czechia.
Who is sponsoring the NCT07206199 clinical trial?
NCT07206199 is sponsored by National Institute of Mental Health, Czech Republic. The principal investigator is Iveta Hocko Fajnerová, Ph.D. at National Institute of Mental Health (NIMH). The trial plans to enroll 30 participants.